Core Insights - The conference held by Junlebao Dairy Group focused on the release of the "White Paper on Human Milk Oligosaccharides (HMOs) Functions and Applications," highlighting the importance of HMOs in infant nutrition and the company's commitment to research and development in this area [1][3]. Group 1: Research and Development - Junlebao has introduced the "Brain-Body Dual-Excellence" research model, which aims to provide comprehensive nutritional options for infants through scientific formulation [1][3]. - The release of the white paper is supported by systematic research from the Chinese Nutrition Society's infant nutrition expert group, providing a comparative analysis of breast milk data domestically and internationally [3][5]. - The company has made significant breakthroughs in maternal nutrition research, revealing the brain-gut regulatory mechanisms of HMOs and developing nutrient combinations that are easier for infants to absorb [5][7]. Group 2: Industry Positioning - The "Brain-Body Dual-Excellence" model encompasses a comprehensive nutritional formula system that has been recognized as "internationally leading" by the Chinese Institute of Food Science and Technology [7]. - Junlebao's formula, "Youcuibao Aini," has been awarded the "Annual Infant Nutrition Award" for three consecutive years, reflecting the company's strong market position and commitment to quality [7][8]. - The conference emphasized the need for the infant formula industry to shift from merely adding components to focusing on functional mechanisms and synergistic effects, aiming to establish a Chinese standard for maternal nutrition research [10].